Tag: patent challenge
180-Day Exclusivity: How Patent Law Delays Generic Drug Entry
Posted by Desmond Carrington on 9/03/26
The 180-day exclusivity rule was meant to speed up generic drugs, but it often delays them. Companies use it to block competitors for years - and patients pay the price.
Hatch-Waxman Act: How Federal Law Shapes Generic Drug Approval in the U.S.
Posted by Desmond Carrington on 4/12/25
The Hatch-Waxman Act created the modern system for generic drug approval in the U.S., balancing innovation with affordability. It cut approval costs, enabled 90% generic market share, and saved over $1.7 trillion-but patent games still delay access.
